Managers

ClearDATA nabs $26 mln

Austin, Texas-based ClearDATA, a security and compliance expert in the healthcare cloud, has raised $26 million in financing. The investors included Humana Inc, Health Care Service Corporation, Norwest Venture Partners, Merck GHIF, Excel Venture Management, Heritage Group, HLM Venture Partners and Flare Capital Partners.

Emerging manager roundup: Health Velocity, Base10 Partners, Bluepoint and more

500 Startups wraps up oversubscribed Vietnam fund

500 Startups, which operates worldwide micro-funds, announced it has raised $14 million in an oversubscribed Vietnam-focused fund. The fund, launched in 2016, had targeted initially to raise $10 million. In a blog post, 500 Startups said it has already invested nearly $3 million in 36 companies to date, with a focus on companies serving the Vietnam market or leveraging Vietnamese talent. The fund is led by Eddie Thai (a Vietnam-based entrepreneur) and Binh Tran (co-founder and former CTO of Klout).

DLA Piper’s Ignacio Sanchez on CFIUS’ new regulations and pilot program

Buyout-backed tech deals on record pace in 2018

Camel-IDS takes in Series A funding

Camel-IDS, a Belgian developer of cancer-targeted radiopharmaceuticals, has secured 37 million euros in Series A funding. V-Bio Ventures and Gimv led the round with participation from other investors that included HealthCap, Novo Seeds, Pontifax and BioMedPartners.

USC Marshall School of Business launches venture fund

The USC Marshall School of Business has launched a venture capital fund. The fund will invest in early-stage startups founded by USC students, alumni, faculty and staff. No financial terms were disclosed.

QurAlis pulls in $5.5 mln seed

Cambridge, Massachusetts-based QurAlis Corporation, a biotech company focused on developing precision therapeutics for ALS and other neurological diseases, has raised $5.5 million in seed funding. The investors included BioInnovation Capital, Viva Biotech Limited, MP Healthcare Venture Management and Amgen Ventures.

Post Venture Capital Index takes another dive in October

Alphamab nabs more than $100 mln Series A

China-based Alphamab Oncology, a biopharmaceutical company focused on treating cancer, has raised more than $100 million in Series A funding. The investors included Advantech Capital, PAG,OrbiMed, Heritage Provider Network and Janchor Partners.